Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: A systematic review and meta-analysis

The use of high-density lipoprotein cholesterol modifying treatments had no significant effect on cardiovascular mortality, stroke or all-cause mortality. The beneficial effect on myocardial infarction was lost when drugs were used with statin therapy.